The Israeli medical cannabis company Univo acquires the Medipharm pharmacy

The Israeli medical cannabis company Univo has taken control of the Medipharm pharmacy for $ 1.7 million. Medipharm, based in Holon, sells medical cannabis direct to customers, including direct to patients’ homes through their website.

The acquisition of Medipharm is a step in Univo’s strategy to become an independent company with complete control over the medical cannabis production chain, from cultivation to production and distribution to delivery. Univo sells in over 140 pharmacies, including pharmacies in the Super Pharm and BE chains.

“As a leading company in the medical cannabis market, by purchasing a leading pharmacy, we have achieved complete control over the value chain from pharmacy to end user and thus deepened the connection with our patients,” said CEO and founder of Univo Golan Bitton in a Explanation.

“We assume that the acquisition of Medipharm will enable the company to grow sales and profits as well as increase market share. In addition, our control over the entire value chain allows us the maximum operational flexibility and price flexibility required in the cannabis market while maintaining profitability. We are still looking into further collaborations in Israel and abroad to create value for our shareholders. “

Israel legalized medical cannabis in the early 1990s and came into pharmacies in 2018. Super Pharm outlets began selling cannabis oil in cities across the country from two Israeli suppliers.

cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});

if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}

Source link

You May Also Like